Korean Circ J.  2017 Jul;47(4):483-489. 10.4070/kcj.2016.0400.

Aortic Flow Propagation Velocity in Patients with Familial Mediterranean Fever: an Observational Study

Affiliations
  • 1Department of Cardiology, Gaziosmanpasa University School of Medicine, Tokat, Turkey. drkkaraman55@gmail.com
  • 2Department of Radiology, Gaziosmanpasa University School of Medicine, Tokat, Turkey.
  • 3Department of Internal Medicine, Gaziosmanpasa University School of Medicine, Tokat, Turkey.
  • 4Department of Cardiology, Erzurum Territorial Training and Research Hospital, Erzurum, Turkey.

Abstract

BACKGROUND AND OBJECTIVES
Systemic inflammation has an important role in the initiation of atherosclerosis, which is associated with arterial stiffness (AS). Aortic flow propagation velocity (APV) is a new echocardiographic parameter of aortic stiffness. The relationship between systemic inflammation and AS has not yet been described in patients with familial Mediterranean fever (FMF). We aimed to investigate the early markers of AS in patients with FMF by measuring APV and carotid intima-media thickness (CIMT).
SUBJECTS AND METHODS
Sixty-one FMF patients (43 women; mean age 27.3±6.7 years) in an attack-free period and 57 healthy individuals (36 women; mean age 28.8±7.1 years) were included in this study. The individuals with atherosclerotic risk factors were excluded from the study. The flow propagation velocity of the descending aorta and CIMT were measured to assess AS.
RESULTS
APV was significantly lower (60.2±16.5 vs. 89.5±11.6 cm/sec, p<0.001) and CIMT was significantly higher (0.49±0.09 vs. 0.40±0.10 mm, p<0.001) in the FMF group compared to the control group. There were significant correlations between APV and mean CIMT (r=-0.424, p<0.001), erythrocyte sedimentation rate (ESR) (r=-0.198, p=0.032), and left ventricle ejection fraction (r=0.201, p=0.029). APV and the ESR were independent predictors of FMF in logistic regression analysis (OR=-0.900, 95% CI=0.865-0.936, p<0.001 and OR=-1.078, 95% CI=1.024-1.135, p=0.004, respectively). Mean CIMT and LVEF were independent factors associated with APV in linear regression analysis (β=-0.423, p<0.001 and β=0.199, p=0.017, respectively).
CONCLUSION
We demonstrated that APV was lower in FMF patients and is related to CIMT. According to our results, APV may be an independent predictor of FMF.

Keyword

Familial Mediterranean fever; Aortic flow propagation velocity; Arterial stiffness; Carotid intima-media thickness

MeSH Terms

Aorta, Thoracic
Atherosclerosis
Blood Sedimentation
Carotid Intima-Media Thickness
Echocardiography
Familial Mediterranean Fever*
Female
Heart Ventricles
Humans
Inflammation
Linear Models
Logistic Models
Observational Study*
Risk Factors
Vascular Stiffness

Figure

  • Fig. 1 Measurement of APV in a subject in the control group (A) and in a patient with FMF (B). APV: aortic flow propagation velocity, FMF: familial Mediterranean fever.

  • Fig. 2 Correlation between APV and CIMT. APV: aortic flow propagation velocity, CIMT: mean carotid intima-media thickness, FMF: familial Mediterranean fever.

  • Fig. 3 Receiver–operating characteristic curve analysis showing the sensitivity and specificity of APV ≤69.6 for predicting the CIMT. APV: aortic flow propagation velocity, AUC: area under curve, CI: confidence interval.


Reference

1. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998; 351:659–664. PMID: 9500348.
2. Stoffman N, Magal N, Shohat T, et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet. 2000; 8:307–310. PMID: 10854115.
3. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001; 9:473–483. PMID: 11464238.
4. Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis. 2004; 63:952–955. PMID: 15051620.
5. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27:2588–2605. PMID: 17000623.
6. Simsek H, Sahin M, Gunes Y, Dogan A, Gumrukcuoglu HA, Tuncer M. A novel echocardiographic method for the detection of subclinical atherosclerosis in newly diagnosed, untreated type 2 diabetes. Echocardiography. 2013; 30:644–648. PMID: 23347332.
7. Sen T, Tufekcioglu O, Ozdemir M, et al. New echocardiographic parameter of aortic stiffness and atherosclerosis in patients with coronary artery disease: aortic propagation velocity. J Cardiol. 2013; 62:236–240. PMID: 23778004.
8. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997; 40:1879–1885. PMID: 9336425.
9. Akcay A, Acar G, Sayarlioglu M, et al. QT dispersion and transmural dispersion of repolarization in patients with familial Mediterranean fever. Mod Rheumatol. 2009; 19:550–555. PMID: 19578931.
10. Kaya EB, Yorgun H, Akdogan A, et al. Heart-rate recovery index is impaired in Behçet's disease. Tex Heart Inst J. 2009; 36:282–286. PMID: 19693299.
11. Rozenbaum M, Naschitz JE, Yudashkin M, et al. Cardiovascular autonomic dysfunction in familial Mediterranean fever. J Rheumatol. 2002; 29:987–989. PMID: 12022362.
12. Levy M, Ehrenfeld M, Levo Y, Fischel R, Zlotnick A, Eliakim M. Circulating immune complex in recurrent polyserositis. (Familial mediterranean fever periodic disease). J Rheumatol. 1980; 7:886–890. PMID: 7205826.
13. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003; 349:2399–2406. PMID: 14681505.
14. Thenappan T, Ali Raza J, Movahed A. Aortic atheromas: current concepts and controversies-a review of the literature. Echocardiography. 2008; 25:198–207. PMID: 18269565.
15. Caliskan M, Gullu H, Yilmaz S, et al. Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis. 2007; 195:e161–e167. PMID: 17673217.
16. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilatation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994; 24:1468–1474. PMID: 7930277.
17. Demiralp E, Kardesoglu E, Kiralp MZ, et al. Aortic elasticity in patients with ankylosing spondylitis. Acta Cardiol. 2004; 59:630–634. PMID: 15636447.
18. Bicer A, Acikel S, Kilic H, et al. Impaired aortic elasticity in patients with psoriasis. Acta Cardiol. 2009; 64:597–602. PMID: 20058504.
19. Wright CI, Brouwer-de Cock KA, Kroner CI, Hoeks AP, Draijer R. The relation of arterial stiffness to endothelial function in healthy subjects. Physiol Meas. 2007; 28:573–582. PMID: 17470989.
20. Duprez DA, Cohn JN. Arterial stiffness as a risk factor for coronary atherosclerosis. Curr Atheroscler Rep. 2007; 9:139–144. PMID: 17877923.
21. Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol. 1993; 21:144–150. PMID: 8417055.
22. Güneş A, Güntekin Ü, Yıldız S, et al. Association of aortic flow propagation velocity with ankle-brachial blood pressure index in patients with hypertension: an observational study. Anadolu Kardiyol Derg. 2012; 12:568–573. PMID: 22877895.
23. Güneş Y, Tuncer M, Yildirim M, Güntekin U, Gümrükçüoğlu HA, Şahin M. A novel echocardiographic method for the prediction of coronary artery disease. Med Sci Monit. 2008; 14:MT42–MT46. PMID: 18758427.
24. Yiu KH, Yeung CK, Chan HT, et al. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol. 2011; 164:514–520. PMID: 21039409.
25. Mäki-Petäjä KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation. 2006; 114:1185–1192. PMID: 16952987.
26. Yildiz M, Masatlioglu S, Seymen P, Aytac E, Sahin B, Seymen HO. The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever. Can J Cardiol. 2006; 22:1127–1131. PMID: 17102830.
27. Berkun Y, Padeh S, Reichman B, et al. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. Semin Arthritis Rheum. 2007; 37:182–188. PMID: 17512038.
28. Yildirim K, Uzkeser H, Keles M, et al. Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever. Biochemia Med (Zagreb). 2012; 22:109–113.
29. Ossareh S, Alaei A, Saedi D. Carotid intima-media thickness in maintenance hemodialysis patients: role of cardiovascular risk factor. Iran J Kidney Dis. 2011; 5:169–174. PMID: 21525576.
30. Ugurlu S, Seyahi E, Cetinkaya F, Ozbakir F, Balci H, Ozdogan H. Intima-media thickening in patients with familial Mediterranean fever. Rheumatology (Oxford). 2009; 48:911–915. PMID: 19478036.
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr